生物活性 体外研究 体内研究 CEP-28122 (Mesylate salt) 试剂级价格
ChemicalBook  CAS数据库列表  CEP-28122 (Mesylate salt)

CEP-28122 (Mesylate salt)

CEP-28122 (Mesylate salt),,结构式
CEP-28122 (Mesylate salt)
  • CAS号:
  • 英文名:CEP-28122 (Mesylate salt)
  • 中文名:CEP-28122 (Mesylate salt)
  • CBNumber:CB22666785
  • 分子式:C??H??ClN?O?S
  • 分子量:0
  • MOL File:Mol file
CEP-28122 (Mesylate salt)化学性质
  • 形态 :Solid
  • 颜色 :White to off-white

CEP-28122 (Mesylate salt)性质、用途与生产工艺

  • 生物活性 CEP-28122 mesylate salt 是一种二氨基嘧啶衍生物,是一种高度有效的选择性且具有口服活性的 ALK 抑制剂,对重组 ALK 激酶活性的 IC50 为 1.9 nM。CEP-28122 在人类癌症的 ALK 阳性实验模型中具有抗肿瘤活性。 CEP-28122 具有良好的药效药代活性。
  • 体外研究

    CEP-28122 mesylate salt (3-3000 nM; 48 hours) treatment leads to concentration-dependent growth inhibition of Karpas-299 and Sup-M2 cells in culture, associates with concentration-related caspase 3/7 activation. CEP-28122 mesylate salt (30-1000 nM; 2 hours) treatment leads to substantial suppression of phosphorylation of putative downstream effectors of ALK in Sup-M2 cells, indicating that the downstream signaling pathways are mediated by individual ALK fusion protein.

    Cell Cytotoxicity Assay

    Cell Line: Karpas-299, Sup-M2, Toledo and HuT-102 cells
    Concentration: 10 nM, 100 nM, 1000 nM, 10000 nM
    Incubation Time: 48 hours
    Result: Treatment led to concentration-dependent growth inhibition of Karpas-299 and Sup-M2 cells in culture.

    Western Blot Analysis

    Cell Line: Sup-M2 cells
    Concentration: 30 nM, 100 nM, 300 nM, 1000 nM
    Incubation Time: 2 hours
    Result: Resulted in substantial suppression of phosphorylation of putative downstream effectors of ALK, including Stat-3, Akt, and ERK1/2 in Sup-M2 cells.
  • 体内研究

    CEP-28122 mesylate salt (3-30 mg/kg; oral gavage; twice a day; 12 days) produces dose-dependent antitumor activity in Sup-M2 subcutaneous tumor xenografts in SCID mice.In contrast, CEP-28122 has no antitumor activity in nu / nu mice bearing HCT116, suggesting that the antitumor activity of CEP-28122 in NPM-ALK–positive Sup-M2 tumor models is due to sustained NPM-ALK inhibition in tumors .

    Animal Model: Female SCID mice bearing Sup-M2 subcutaneous tumor xenografts and nu / nu mice bearing HCT116 aged 6-8 week old
    Dosage: 3 mg/kg, 10 mg/kg and 30 mg/kg
    Administration: oral gavage; twice a day; 12 days
    Result: CEP-28122 produced dose-dependent antitumor activity in Sup-M2 subcutaneous tumor xenografts in SCID mice. In contrast, CEP-28122 had no antitumor activity in nu / nu mice bearing HCT116.
CEP-28122 (Mesylate salt)上下游产品信息
上游原料
下游产品
CEP-28122 (Mesylate salt) 试剂级价格
  • 更新日期:2024/11/08
  • 产品编号:HY-18030A
  • 产品名称:CEP-28122 (Mesylate salt) CEP-28122 mesylate salt
  • CAS编号:
  • 包装:5 mg
  • 价格:1500元
  • 更新日期:2024/11/08
  • 产品编号:HY-18030A
  • 产品名称:CEP-28122 (Mesylate salt) CEP-28122 mesylate salt
  • CAS编号:
  • 包装:10 mM * 1 mLin DMSO
  • 价格:2096元
CEP-28122 (Mesylate salt)生产厂家
  • 公司名称:MedChemexpress LLC
  • 联系电话:021-58955995
  • 电子邮件:sales@medchemexpress.cn
  • 国家:美国
  • 产品数:4861
  • 优势度:58
  • 公司名称:TargetMol Chemicals Inc.
  • 联系电话:
  • 电子邮件:support@targetmol.com
  • 国家:美国
  • 产品数:38631
  • 优势度:58
  • 公司名称:MedChemExpress
  • 联系电话:--
  • 电子邮件:sales@medchemexpress.com
  • 国家:美国
  • 产品数:6398
  • 优势度:58